Listed by the USPTO as JONES-FOSTER, ERICA NICOLE
Tech Center 1600 • Art Units: 1612 1644 1655 1656
This examiner grants 49% of resolved cases
JONES-FOSTER, ERICA NICOLE works in Tech Center 1600 and Art Unit 1612. Her profile includes 83 resolved cases and a 49.4% allowance rate. The allowance result is near an even split across the recorded docket, so applicants should not assume that prosecution will routinely conclude with allowance without focused claim and prior-art analysis.
The interview lift is 44.0%, a substantial positive association in this profile. That figure makes interview preparation a potentially important part of prosecution planning, particularly where claim distinctions can be explained more effectively through examiner discussion. The median time to allowance is 1268 days, indicating a lengthy observed path to allowance. The leading companies are Merck Sharp & Dohme LLC, Novozymes A/S, and Hanmi Pharm. Co., Ltd. The listed firms are GOODWIN PROCTER LLP, SUGHRUE MION, PLLC, and TRASKBRITT, P.C.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17784693 | Methods and compositions for modulating the glycosylation profile of proteins | Non-Final OA | Merck Patent GmbH |
| 17185196 | GENETICALLY MODIFIED BACTERIAL CELLS AND METHODS USEFUL FOR PRODUCING TETRAMETHYL PYRAZINE | Final Rejection | The Regents of the University of California |
| 17437232 | MICROBIAL TEST KIT, MICROBIAL TEST METHOD AND MICROBIAL TEST DEVICE | Non-Final OA | HITACHI HIGH-TECH CORPORATION |
| 17795939 | COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 17040448 | DEVICE FOR MANUFACTURING ORGANIC SUBSTANCE, AND GAS PROCESSING SYSTEM | Final Rejection | SEKISUI CHEMICAL CO., LTD. |
| 18594431 | METHOD FOR IDENTIFYING CANDIDATE THERAPEUTICS FOR ALZHEIMER'S DISEASE | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 18245872 | GENERATION OF A HIGH PRODUCING RECOMBINANT CHINESE HAMSTER OVARY CELL LINE FOR THERAPEUTIC PROTEIN PRODUCTION | Final Rejection | SANOFI |
| 17435555 | Detergent Compositions Comprising Two Proteases | Final Rejection | Novozymes A/S |
| 17299273 | Powder Detergent Compositions | Non-Final OA | Novozymes A/S |
| 18260225 | Methods and Compositions for Making Amide Compounds | Final Rejection | Genomatica, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy49.4% of resolved applications examined by Erica Nicole Jones-Foster were allowed (83 resolved cases), compared with 40.7% across Art Unit 1612 over the last five years.
This examiner's interview lift is +44.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Erica Nicole Jones-Foster took 1,268 days on average from filing to allowance.
Erica Nicole Jones-Foster examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
